Company record
PATH
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about PATH.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Dec 24, 2025 | Class II | PATH Device |
MADSEN ACCUSCREEN TEOAE/DPOAE/ABR Probe (P/N 8-69-41100) Following a component change in the DPOAE probe (speaker replacement), technical distortions may occur at high stimulus levels combined with unusually low OAE amplitude acceptance thresholds. These distortions can mimic true DPOAE responses and may result in a false PASS outcome. FDA notice Z-0940-2026 |